147 related articles for article (PubMed ID: 25792355)
1. Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q.
Heuser M; Meggendorfer M; Cruz MM; Fabisch J; Klesse S; Köhler L; Göhring G; Ganster C; Shirneshan K; Gutermuth A; Cerny-Reiterer S; Krönke J; Panagiota V; Haferlach C; Koenecke C; Platzbecker U; Thiede C; Schroeder T; Kobbe G; Ehrlich S; Stamer K; Döhner K; Valent P; Schlegelberger B; Kroeger N; Ganser A; Haase D; Haferlach T; Thol F
Leukemia; 2015 Sep; 29(9):1942-5. PubMed ID: 25792355
[No Abstract] [Full Text] [Related]
2. TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
Jädersten M; Saft L; Smith A; Kulasekararaj A; Pomplun S; Göhring G; Hedlund A; Hast R; Schlegelberger B; Porwit A; Hellström-Lindberg E; Mufti GJ
J Clin Oncol; 2011 May; 29(15):1971-9. PubMed ID: 21519010
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
[TBL] [Abstract][Full Text] [Related]
4. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.
Schneider RK; Ademà V; Heckl D; Järås M; Mallo M; Lord AM; Chu LP; McConkey ME; Kramann R; Mullally A; Bejar R; Solé F; Ebert BL
Cancer Cell; 2014 Oct; 26(4):509-20. PubMed ID: 25242043
[TBL] [Abstract][Full Text] [Related]
5. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
[TBL] [Abstract][Full Text] [Related]
6. The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q--new prognostic markers are needed.
Kuendgen A
Leuk Res; 2014 Mar; 38(3):287-8. PubMed ID: 24433864
[No Abstract] [Full Text] [Related]
7. NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
Fidler C; Watkins F; Bowen DT; Littlewood TJ; Wainscoat JS; Boultwood J
Haematologica; 2004 Jul; 89(7):865-6. PubMed ID: 15257941
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan.
Tasaka T; Tohyama K; Kishimoto M; Ohyashiki K; Mitani K; Hotta T; Kanamaru A; Okamoto S; Karasawa M; Kimura A; Tomonaga M; Uchiyama T; Ozawa K;
Leukemia; 2008 Oct; 22(10):1874-81. PubMed ID: 18668133
[TBL] [Abstract][Full Text] [Related]
9. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
10. Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis.
Zemanova Z; Michalova K; Buryova H; Brezinova J; Kostylkova K; Bystricka D; Novakova M; Sarova I; Izakova S; Lizcova L; Ransdorfova S; Krejcik Z; Merkerova MD; Dohnalova A; Siskova M; Jonasova A; Neuwirtova R; Cermak J
Leuk Res; 2014 May; 38(5):537-44. PubMed ID: 24636338
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients.
Douet-Guilbert N; De Braekeleer E; Basinko A; Herry A; Gueganic N; Bovo C; Trillet K; Dos Santos A; Le Bris MJ; Morel F; Eveillard JR; Berthou C; De Braekeleer M
Leukemia; 2012 Jul; 26(7):1695-7. PubMed ID: 22290067
[No Abstract] [Full Text] [Related]
13. In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time.
Lauseker M; Schemenau J; Strupp C; Kündgen A; Gattermann N; Hasford J; Germing U
Br J Haematol; 2015 Sep; 170(5):687-93. PubMed ID: 25960152
[TBL] [Abstract][Full Text] [Related]
14. The molecular pathogenesis of the myelodysplastic syndromes.
Pellagatti A; Boultwood J
Eur J Haematol; 2015 Jul; 95(1):3-15. PubMed ID: 25645650
[TBL] [Abstract][Full Text] [Related]
15. Familial MDS with 5q- abnormality.
Grimwade DJ; Stephenson J; De Silva C; Dalton RG; Mufti GJ
Br J Haematol; 1993 Jul; 84(3):536-8. PubMed ID: 8217806
[TBL] [Abstract][Full Text] [Related]
16. The 5q- syndrome: a scientific and clinical update.
Tefferi A; Mathew P; Noël P
Leuk Lymphoma; 1994 Aug; 14(5-6):375-8. PubMed ID: 7812195
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P.
Zagaria A; Coccaro N; Tota G; Anelli L; Minervini A; Casieri P; Cellamare A; Minervini CF; Brunetti C; Ricco A; Orsini P; Cumbo C; Specchia G; Albano F
Blood Cells Mol Dis; 2015 Jan; 54(1):51-2. PubMed ID: 25159121
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived CK1α mutations enhance MDMX inhibition of p53.
Liu X; Huang Q; Chen L; Zhang H; Schonbrunn E; Chen J
Oncogene; 2020 Jan; 39(1):176-186. PubMed ID: 31462704
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
Haferlach C; Bacher U; Tiu R; Maciejewski JP; List A
Cancer Genet Cytogenet; 2008 Dec; 187(2):101-11. PubMed ID: 19027491
[TBL] [Abstract][Full Text] [Related]
20. MDS with del(5q) and associated cKIT D816V positive mastocytosis.
Chan N; Tan SY; Opat S; Shortt J
Pathology; 2012 Aug; 44(5):492-3. PubMed ID: 22777071
[No Abstract] [Full Text] [Related]
[Next] [New Search]